3D Global Biotech Inc. (6808.TWO)

TWD 49.2

(0.51%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 20.63 Million 13.64 Million 11.07 Million 13.26 Million 18.17 Million
Cost of Revenue 15.35 Million 10.92 Million 9.27 Million 8.29 Million 10.25 Million
Gross Profit 5.27 Million 2.71 Million 1.8 Million 4.97 Million 7.92 Million
Operating Expenses 5.27 Million 69 Million 64.01 Million 55.29 Million 41.62 Million
Selling, General and Administrative Expenses 29.53 Million 29.52 Million 26.41 Million 19.68 Million 29.71 Million
Research and Development Expenses 38.59 Million 39.47 Million 37.59 Million 35.61 Million -
Other Expenses - -18.27 Million 155 Thousand 241 Thousand -
Cost and Expenses 83.48 Million 79.93 Million 73.28 Million 63.58 Million 51.88 Million
Operating Income -62.85 Million -82.87 Million -60.7 Million -48.37 Million -36.3 Million
Interest Expense 176 Thousand 255 Thousand 261 Thousand 101 Thousand 49 Thousand
Income Tax Expense -964 Thousand -16.04 Million -1.26 Million -560 Thousand 2.56 Million
Earnings before Tax -58.91 Million -83.13 Million -60.96 Million -48.47 Million -33.75 Million
Net Income -57.95 Million -67.08 Million -59.7 Million -47.91 Million -36.31 Million
Earnings Per Share Basic -1.03 -1.22 -1.11 -0.89 -0.72
Earnings Per Share Diluted -1.03 -1.22 -1.11 -0.89 -0.72
Weighted Average Shares Outstanding 56.15 Million 54.88 Million 53.97 Million 53.55 Million 50.51 Million
Weighted Average Shares Outstanding (Diluted) 56.15 Million 54.88 Million 53.97 Million 53.55 Million 50.51 Million
Gross Margin 0.26 0.20 0.16 0.37 0.44
EBIT Margin -1.74 -4.18 -3.23 -1.81 -1.38
Profit Margin -2.81 -4.92 -5.39 -3.61 -2.00
EBITDA -35.84 Million -57.01 Million -35.81 Million -24.03 Million -18.15 Million
Earnings Before Tax Margin -3.05 -6.07 -5.48 -3.65 -2.00

Income Statement Charts